Gueulette John, Octave-Prignot Michèle, De Costera Blanche-Marie, Wambersie André, Grégoire Vincent
Laboratory of Radiobiology and Radioprotection, Department of Medicine, Catholic University of Louvain, Belgium.
Radiother Oncol. 2004 Dec;73 Suppl 2:S148-54. doi: 10.1016/s0167-8140(04)80038-0.
The Relative Biological Effectiveness (RBE) of 8 fast-neutron beams, 5 proton beams and 1 carbonion beam was determined using as biological criterion intestinal crypt regeneration in mice, i.e. an in vivo system. These beams are used or planned for clinical cancer therapy applications. In addition, the RBE of 6 epithermal neutron beams, used or planned for Boron Neutron Capture Therapy (BNCT), was determined; no boron was administered. The goal of the program was to improve the exchange of information between the centers, facilitate the interpretation of the results and increase the safety of the clinical applications.
In all visited centers, the same technique was applied in the same conditions by the same radiobiology team. The number of regenerating crypts per circumference was scored 3.5 days after single fraction total body irradiation. The control irradiations were performed locally using cobalt-60 units. The mice were randomized according to radiation quality and dose level.
(1) For fast neutron beams, the RBE (Ref. cobalt-60 gamma rays) increases with decreasing energy (from approximately 1.7 for p(65)+Be neutrons to approximately 2.4 for d(14.5)+Be neutrons). In addition, it is specific to each facility and depends on the nuclear reaction (p or d + Be), target and collimation type. (2) For proton beams, the RBEs (Ref cobalt-60 gamma rays) at the reference position (middle of a 7-cm Spread Out Bragg Peak, SOBP) range between 1.08 and 1.18. They might differ by approximately 6-8% according to the mode of beam production or delivery. The RBEs at the end of the SOBP are always 5-10 % higher than at the middle of the SOBP. (3) For the carbon ion beam studied at NIRS in Chiba, Japan, the RBE significantly increases with depth. Relative to gamma rays, it ranges from 1.3 in the initial plateau, 1.6 at the beginning, 1.7 at the middle and 1.9 at the end of a 6-cm SOBP. 4) In BNCT beams, the radiation quality (in particular the relative contribution of the different dose components) varies rapidly with depth and depends strongly on the arrangement of the irradiation set-up (e.g. presence or not of back scattering material). Moreover, the (total) dose rates are highly variable (from 0.05 to approximately 0.5 Gy/min) according to the power of the reactors. Wide range of RBE values (Ref. gamma rays) was thus obtained (RBE = 1.4 - 2.2) at shallow depths of 1.5 - 2.5 cm.
Intestinal crypt regeneration in mice is an in vivo system perfectly suitable to perform intercomparisons between centers applying different types of non-conventional radiation qualities. It was proven to be reproducible, reliable and accurate, and becomes progressively recognized worldwide as part of the Quality Control (QA) procedures for new beams. It should be stressed that the observed RBE for intestinal crypt cells after a single high dose provide some radiobiological characterization of the radiation quality but cannot be used as the RBE weighting factor in clinical prescriptions.
使用小鼠肠道隐窝再生这一生物学标准(即一种体内系统),测定了8种快中子束、5种质子束和1种碳离子束的相对生物效应(RBE)。这些束流已用于或计划用于临床癌症治疗。此外,还测定了6种用于或计划用于硼中子俘获治疗(BNCT)的超热中子束的RBE;未施用硼。该项目的目标是改善各中心之间的信息交流,便于结果的解读,并提高临床应用的安全性。
在所有访问的中心,同一放射生物学团队在相同条件下采用相同技术。单次全身照射3.5天后,对每个圆周上再生隐窝的数量进行评分。对照照射使用钴-60装置局部进行。小鼠根据辐射质量和剂量水平随机分组。
(1)对于快中子束,RBE(参考钴-60γ射线)随能量降低而增加(从p(65)+Be中子的约1.7增加到d(14.5)+Be中子的约2.4)。此外,它因每个设施而异,并取决于核反应(p或d + Be)、靶和准直类型。(2)对于质子束,参考位置(7厘米扩展布拉格峰(SOBP)中部)的RBE(参考钴-60γ射线)在1.08至1.18之间。根据束流产生或输送方式的不同,它们可能相差约6-8%。SOBP末端的RBE总是比SOBP中部高5-10%。(3)对于日本千叶国立放射科学研究所研究的碳离子束,RBE随深度显著增加。相对于γ射线,在6厘米SOBP的初始平台期为1.3,开始时为1.6,中部为1.7,末端为1.9。4)在BNCT束中,辐射质量(特别是不同剂量成分的相对贡献)随深度迅速变化,并且强烈取决于照射装置的布置(例如是否存在反向散射材料)。此外,根据反应堆功率的不同,(总)剂量率变化很大(从0.05到约0.5 Gy/分钟)。因此,在1.5 - 2.5厘米的浅深度处获得了广泛的RBE值范围(参考γ射线)(RBE = 1.4 - 2.2)。
小鼠肠道隐窝再生是一种体内系统,非常适合在应用不同类型非常规辐射质量的中心之间进行相互比较。事实证明它具有可重复性、可靠性和准确性,并逐渐被全世界认可为新束流质量控制(QA)程序的一部分。应该强调的是,单次高剂量后观察到的肠道隐窝细胞的RBE提供了一些辐射质量的放射生物学特征,但不能用作临床处方中的RBE加权因子。